Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,126
Total Claims
$1.7M
Drug Cost
188
Beneficiaries
$9,233
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-57%
Opioid rate vs peers
1.6% vs 3.8% avg
+686%
Cost per patient vs peers
$9,233 vs $1,174 avg
+132%
Brand preference vs peers
20.5% vs 8.9% avg
🔎 Data Overview
Cost per patient is 686% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.6%
Opioid Rate
163
Opioid Claims
$3,351
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,064 claims · $1.5M
Generic: 7,984 claims · $191K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tezepelumab-Ekko | 179 | $773K |
| Icosapent Ethyl | 315 | $111K |
| Dulaglutide | 89 | $86K |
| Exenatide Microspheres | 86 | $72K |
| Linaclotide | 98 | $52K |
| Fluticasone Propionate | 124 | $48K |
| Mirabegron | 101 | $47K |
| Rivaroxaban | 70 | $40K |
| Insulin Glargine,hum.Rec.Anlog | 114 | $39K |
| Apixaban | 56 | $33K |
| Dapagliflozin Propanediol | 49 | $29K |
| Fluticasone/Vilanterol | 50 | $21K |
| Empagliflozin/Metformin Hcl | 23 | $14K |
| Budesonide | 48 | $13K |
| Albuterol Sulfate | 212 | $13K |
Prescribing Profile
Patient Profile
59
Avg Age
43%
Female
1.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data